Clinical Trial Update: Biologic Augmentation With Mesenchymal Stem Cells in Patients Undergoing Anterior Cruciate Ligament Reconstruction [NA]

View source ↗

Summary

Clinical trial update on biologic augmentation with mesenchymal stem cells for anterior cruciate ligament reconstruction, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anterior Cruciate Ligament Injury
• Anterior Cruciate Ligament Rupture

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Rush University Medical Center | Conditions: Anterior Cruciate Ligament Injury, Anterior Cruciate Ligament Rupture | NA | Status: ENROLLING_BY_INVITATION